Articles
| Open Access |
DOI: DEVELOPMENT AND VALIDATION OF AN RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF COBICISTAT AND ATAZANAVIR IN BULK AND PHARMACEUTICAL DOSAGE FORM
G Ravikumar , Professor in Dept. Of Physical Chemistry, Osmania University, Hyderabad, Telangana, IndiaAbstract
This research paper focuses on the development and validation of an RP-HPLC (Reverse-Phase High-Performance Liquid Chromatography) method for the simultaneous estimation of cobicistat and atazanavir in bulk and pharmaceutical dosage form. Cobicistat and atazanavir are important antiretroviral drugs used in the treatment of HIV infection. The development of a reliable and accurate analytical method for their simultaneous determination is essential for quality control and pharmacokinetic studies. The RP-HPLC method was optimized by considering factors such as column selection, mobile phase composition, flow rate, and detection wavelength. Validation parameters including linearity, precision, accuracy, specificity, robustness, and system suitability were evaluated according to international guidelines. The developed method demonstrated good linearity, sensitivity, and selectivity for the simultaneous estimation of cobicistat and atazanavir in both bulk and pharmaceutical dosage form. The findings of this study provide a robust and reliable analytical method that can be utilized for routine analysis and quality control of cobicistat and atazanavir formulations.
Keywords
RP-HPLC, Cobicistat, Atazanavir
References
http://en.wikipedia.org/wiki/Cobicistat.
http://www.drugs.com/mtm/cobicistat.html.
http://en.wikipedia.org/wiki/atazanavir
http://www.drugs.com/cdi/atazanavir.html.
http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206353s000lbl.pdf.
Eve-Irene Lepist Et al., Cobicistat Booststhe Intestinal Absorption of TransportSubstrates, Including HIV Protease Inhibitorsand GS-7340, In Vitr, Antimicrobial AgentsChemother., Vol 56(10), pg 5409-5413. oct2012.
7. Kavitha K, Geetha Y, Hariprasad G,Venkatnarayana R and Subramanian R(Jan, 2013) “Development and Validation ofRp-hplc Analytical Method For SimultaneousEstimation of Emtricitabine, Rilpivirine,Tenofovir Disoproxil Fumarate And ItsPharmaceutical Dosage Forms”, AcademicJournal Pharmacie Globale, [Online], Vol. 4No. 1, P. 1.
Charushila H B and Shivanand N H (2013),Stability Indicating RP-HPLC Method for theDetermination of Atazanavir Sulphate in Bulkand Dosage Form”, Drug Invention Today,Vol. 5, pp. 81-86.
Reddy B V, Jyothi G, Reddy B S, Raman NV, Reddy K S and Rambabu C (2013),Stability-indicating HPLC Method for theDetermination of Darunavir Ethanolate”, JChromatogr Sci., Vol. 51, pp. 471-476.
Tulsidas Mishra and Pranav S S (2014),“Validation of Simultaneous QuantitativeMethod of HIV Protease Inhibitors Atazanavir,Darunavir and Ritonavir in Human Plasmaby UPLCMS/MS”, The Scientific WorldJournal, pp. 1-12.
Article Statistics
Copyright License
Copyright (c) 2023 The American Journal of Medical Sciences and Pharmaceutical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.